不同血液净化方式对血透患者透析中低血压的影响

doi:10.3969/j.issn.1000-8535.2017.06.013

摘要/Abstract

摘要： 目的观察不同血液净化方式对维持性血液透析(MHD)患者透析中低血压(IDH)的干预作用。方法选择透析中低血压患者30例,随机分为血液透析(HD)组,血液透析滤过(HDF)组,血液灌流联合血液透析(HP+HD)组,各组均为10例。比较三组患者透析中低血压的发生率。分别于首次治疗前、后,治疗24周后测定血清血β₂-微球蛋白(β₂-MG)、N末端B型利钠肽原(NT-proBNP)、血浆白蛋白(ALB)。结果 ①HDF+HD、HP+HD组透析中低血压发生率降低(P<0.05)。②与治疗前相比,首次治疗后HDF能降低血β₂-MG水平(P<0.05);治疗24周后,HP+HD、HDF组均可降低血β₂-MG浓度(P<0.05),且HP+HD组下降更明显(P<0.05)。首次治疗及治疗24周后,HD组均不能降低NT-proBNP水平,而HDF、HP+HD组均能有效降低血NT-proBNP浓度(P<0.05)。首次治疗和治疗24周后3组患者ALB水平的差异均无统计学意义,同期3组患者ALB水平的差异亦不显著(P>0.05)。结论 HDF或HP+HD能有效降低MHD患者IDH的发生率,值得推广。

关键词: 血液透析滤过, 血液灌流, 透析中低血压

Abstract: Objective To explore the efficacy of different blood purification methods on intradialytic hypotension(IDH) in maintenance hemodialysis (MHD) patients. Methods Thirty MHD patients with IDH were randomly divided into three groups: hemodialysis(HD) group(n=10),hemodiafiltration(HDF) group(n=10),hemoperfusion combined with hemodialysis (HP+HD) group(n=10). The changes of blood pressure in therapy and the frequency of intradialytic hypotension were compared.Before and after the first treatment,after 24 weeks of treatment serum blood beta 2-microglobulin(β₂-MG),serum NT-proBNP,albumin(ALB)weremeasured. Results ①Compared with HD group,the frequency of intradialytic hypotension was significantly reduced in HDF and HP+HD group(P<0.05). ② In HFD group serumβ₂-MG decreased after the first dialysis session(P<0.05). After the treatment for 24 weeks, serumβ₂-MG levels decreased in HP+HD and HFD group (P<0.05),especially in HP+HD group(P<0.05). Serum NT-proBNP cannot decreased after first dialysis session and after the treatment for 24 weeks in HD group, however, can decreased in HFD and HP+HD group (P<0.05). There were no changes of ALB levels between three groups after first dialysis session and after the treatment for 24 weeks (P>0.05). Conclusion Hemodiafiltration or hemoperfusion associated with hemodilysis can improve the hemodynamic stability in IDH patients, it can be used as a long term therapy.

Key words: Hemodiafiltration, Hemoperfusion, Intradialytic hypotension

李转欢, 董杰成, 李霞, 张铿. 不同血液净化方式对血透患者透析中低血压的影响[J]. 广州医药, 2017, 48(6): 43-47.

LI Zhuanhuan, DONG Jiecheng, LI Xia, ZHANG Keng. The influence of various blood purification methods on intradialytic hypotension in maintenance dialysis patients[J]. Guangzhou Medical Journal, 2017, 48(6): 43-47.

参考文献

[1] PALMER B F, HENRICH W L. Recent advances in the prevention and management of intradialytic hypotension[J]. Am Soc Nephrol,2008, 19(1):8-11.
[2] ISEKI K, MIYASATO F, TOKUYAMA K,et al. Low diastolicblood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients[J]. Kidney Int,1997,51(4):1212-1217.
[3] SHOJI T, TSUBAKILMM Y, FUJII M,et al. Hemedialysis ssociated hypotension as an independent risk factor for two ear mortality in hemodialysis patients[J]. Kidney Int,2004, 66(3):1212-1220.
[4] 余金波, 邹建洲, 刘中华,等. 维持性血液透析患者透析中低血压的危险因素研究[J]. 中国血液净化,2012,11(4):189-193.
[5] SONG J H, PARK G H, LEE S Y, et al. Effect of sodium balanceand the combination of ultrafiltration profile during sodium profi ling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances[J]. J Am Soc Nephrol, 2005, 16(2): 237-246.
[6] ZHOU Y L, LIU H L, DUAN X F, et al. Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension[J]. Nephrol Dial Transplant, 2006, 21(11):3231-3237.
[7] 朱小华, 王小兵. 血液透析相关性低血压的防治[J]. 淮海医药, 2010, 28(2): 144-145.
[8] 李孜, 杨立川, 陈林,等. 提高透析液钙浓度对透析中低血压患者血流动力学的影响[J]. 中国血液净化,2012,11(3),140-143.
[9] 王晶, 李银辉, 夏春燕,等. 高-低钠结合阶梯式超滤曲线透析对改善血液透析中低血压的临床观察[J]. 中国实用医药,2010,5(16):69-70.
[10] 王宏儒, 鲍晓荣. 不同血液净化方式对维持性血透患者尿毒素清除效果的观察[J]. 中国中西医结合肾病杂志,2013,14(3):215-218.
[11] 李军民, 曾宪飞, 赵花. 相关血清学指标水平在肾衰竭患者不同透析方法治疗中的变化[J]. 国际检验医学杂志,2013,34(2):143-144.
[12] 朱征西,陆绍强,梁碧琴,等. 不同的血液净化方式对维持性血液透析患者微炎症状态的影响[J]. 中国血液净化,2011,10(1):18-21.
[13] KURAGANO T, KIDA, FURUTA M,et al. The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients[J]. ASAIO J,2010,56(4):326-332.
[14] XIE J,YI Q. Beta2-microglobulin as a potential initiator of inflammatory responses[J]. Trends Immunol,2003,24(5): 228-230.
[15] SAIJO Y,UTSUGI M, YOSHIOKA E, et al. Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects[J]. Hypertens Res, 2005, 28(6): 505-511.
[16] 史应进, 王彩丽, 董玉红. 不同血液净化方法对慢性肾功能衰竭维持性血液透析患者血清甲状旁腺素和β2-微球蛋白的影响[J]. 包头医学院学报, 2011, 27(2): 44-47.
[17] 时新杰,李寒,王世相.不同血液净化方式对维持性透析患者中分子毒素清除的研究[J]. 中华临床医师杂志,2012,6(13):3562-3565.
[18] 周咏梅,杨晓红. N-末端脑钠肽前体对预测血液透析患者透析中低血压发生的意义[J]. 临床肾脏病杂志 2013,13(5): 219-221.
[19] PADRINI R,CANOVA C,CONZ P,et al. Convective and adsorptive removal of beta 2 microglobulin during predilutional and postdilutional hemofiltration[J]. Kidney Int, 2005, 68(5):2331-2337.
[20] KONO K, TODA S, HORA K, et al. Direct hemoperfusion with a beta2-microglobulin-selective adsorbent column eliminates inflammatory cytokines and improves pulmonary oxygenation[J]. Ther Apher Dial, 2009, 13(1): 27-33.
[21] 汤学宇,刘丽君,陈燕芳,等,左卡尼汀对透析中低血压患者微炎症和血压的影响[J],现代中西医结合杂志,2012,21( 5):470-531.